Reading Room Production — page 154
of 496 pages
← p.153 p.155 → · this page in the original PDF · package
ol
ol
ay
6 PM
AID DEA DART
NIAID) [E] 7
NIAID) [E]
\IH/NIAID) [E] ii
NIH/NIAID) [E] J
VIH/NIAID) [I] iy
>;
I I
(NIH/NIAID) [E]
NIH/NIAID) [E] ay
NIAID) [E]
1S
)
5 AM
[AID DEA DART
NIAID) (E] i
I
NIAID) [E]
\IH/NIAID) [E] ii
NIH/NIAID) [E] J
VIH/NIAID) [I] iy
>;
I I
(NIH/NIAID) [E]
NIH/NIAID) [E] ay
NIAID) [E]
In the attached revised draft, I
jections, I will submit these to NIH
Thanks,
Sara
From: Selgrade, Sara (NIH/NIAID) [E]
@nih.gov>
Sent: Monday, July 15, 2024 12:26 PM
To: NIAID BUGS
@niaid.nih.gov>; NIAID DEA DART
@mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR-
@mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E]
@nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E]
@niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E]
@niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E]
@niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E]
@niaid.nih.gov>
Cc: NIAID OCGR Leg
@mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E]
@nih.gov>;
Holland, Steven (NIH/NIAID) [E]
@niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E]
@niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E]
@nih.gov>; Gilles, Sharon (NIH/NIAID) [E]
@nih.gov>; DDSM Correspondences
@mail.nih.gov>
Subject: Additional OSP comments: TA on Risky Research Review Act
Hello all,
For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of
Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as
we have them.
Please let me know if you have any questions.
Thanks,
Sara
From: Selgrade, Sara (NIH/NIAID) [E]
@nih.gov>
Sent: Monday, July 15, 2024 10:35 AM
To: NIAID BUGS
@niaid.nih.gov>; NIAID DEA DART
@mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR-
@mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E]
@nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E]
@niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E]
@niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E]
@niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E]
@niaid.nih.gov>
Cc: NIAID OCGR Leg
@mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E]
@nih.gov>;
Holland, Steven (NIH/NIAID) [E]
@niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E]
@niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E]
@nih.gov>; Gilles, Sharon (NIH/NIAID) [E]
@nih.gov>; DDSM Correspondences
@mail.nih.gov>
Subject: For review by noon Monday 7/15: Review draft NIAID TA on Risky Research Review Act
Importance: High
Hello all,
Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I
have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH
OLPA by their noon deadline today.
I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS.
Please let me know if you have any questions or concerns.
Thanks,
Sara
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/reading_room/154
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| For review by noon Monday 7/15: Review draft NIAID TA on Risky Research Review Act | 2024-07-15 | 154–155 | |
| Additional OSP comments: TA on Risky Research Review Act | 2024-07-15 | 154 | |
| Please review by COB today Tues 7/16: HHS Comments to OMB on Risky Research Review Act | 2024-07-16 | 153–154 |